A split face randomized controlled trial comparing 1,064 nm Q-switched Nd-YAG laser and modified Kligman's formulation in patients with melasma in darker skin.
Tanvi DevVishnubhatla SreenivasVinod K SharmaKanika SahniNeetu BhariSethuraman GomathyPublished in: International journal of dermatology (2020)
No statistically significant differences were observed between QSNYL and TC as monotherapy in melasma. Reappearance of melasma is inevitable after stopping treatment.